The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
ABCA7 rare variants and Alzheimer disease risk
Open accessAbstract
OBJECTIVE: To study the association between ABCA7 rare coding variants and Alzheimer disease (AD) in a case-control setting. METHODS: We conducted a whole exome analysis among 484 French patients with early-onset AD and 590 ethnically matched controls. RESULTS: After collapsing rare variants (minor allele frequency ≤1%), we detected an enrichment of ABCA7 loss of function (LOF) and predicted damaging missense variants in cases (odds ratio [OR] 3.40, 95% confidence interval [CI] 1.68-7.35, p = 0.0002). Performing a meta-analysis with previously published data, we found that in a combined sample of 1,256 patients and 1,347 controls from France and Belgium, the OR was 2.81 (95% CI 1.89-4.20, p = 3.60 × 10(-7)). CONCLUSIONS: These results confirm that ABCA7 LOF variants are enriched in patients with AD and extend this finding to predicted damaging missense variants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, rare variants in SORL1 and ABCA7 have been identified in family-based studies of LOAD [147–150], each of which have been associated with alterations in APP processing.”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [150]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,724
Second-generation PLINK: rising to the challenge of larger and richer datasets
Chang, C. C., Chow, C. C., Tellier, L. C., Vattikuti, S., Purcell, S. M., & Lee, J. J. (2015) · Gigascience · doi:10.1186/s13742-015-0047-8 · Cited by 12,709
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Self-citationVariant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558
A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
Jonsson, T., Atwal, J. K., Steinberg, S., Snaedal, J., Jonsson, P. V., Bjornsson, S., Stefansson, H., Sulem, P., Gudbjartsson, D., Maloney, J., et al. (2012) · Nature · doi:10.1038/nature11283 · Cited by 1,738
Cited by
Sorted by citations
Alzheimer Disease Genetics Consortium (ADGC), Kunkle, B. W., The European Alzheimer’s Disease Initiative (EADI), Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE), Genetic and Environmental Risk in AD/Defining Genetic, P. A. E. R. F. A. D. C. (., Grenier-Boley, B., Sims, R., Bis, J. C., Damotte, V., Naj, A. C., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0358-2 · Cited by 2,946
Self-citationMahmoudianDehkordi, S., Arnold, M., Nho, K., Ahmad, S., Jia, W., Xie, G., Louie, G., Kueider‐Paisley, A., Moseley, M. A., Thompson, J. W., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.07.217 · Cited by 706
Late onset Alzheimer’s disease genetics implicates microglial pathways in disease risk
Efthymiou, A. G., & Goate, A. M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0184-x · Cited by 562
30 years of repeat expansion disorders: What have we learned and what are the remaining challenges?
Depienne, C., & Mandel, J.-L. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.03.011 · Cited by 429
Mendez, M. F. (2017) · Neurologic Clinics · doi:10.1016/j.ncl.2017.01.005 · Cited by 389
Untangling Genetic Risk for Alzheimer’s Disease
Pimenova, A. A., Raj, T., & Goate, A. M. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.05.014 · Cited by 223
The role of ABCA7 in Alzheimer’s disease: evidence from genomics, transcriptomics and methylomics
De Roeck, A., Van Broeckhoven, C., & Sleegers, K. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01994-1 · Cited by 212
Structure and Mechanism of Human ABC Transporters
Alam, A., & Locher, K. P. (2023) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-111622-091232 · Cited by 215
Bellenguez, C., Charbonnier, C., Grenier-Boley, B., Quenez, O., Le Guennec, K., Nicolas, G., Chauhan, G., Wallon, D., Rousseau, S., Richard, A. C., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.07.001 · Cited by 166
Self-citationDissecting the clinical heterogeneity of early-onset Alzheimer’s disease
Sirkis, D. W., Bonham, L. W., Johnson, T. P., La Joie, R., & Yokoyama, J. S. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01531-9 · Cited by 151
The genetic landscape of Alzheimer disease
Carmona, S., Hardy, J., & Guerreiro, R. J. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00026-0 · Cited by 140
Genetic architecture of Alzheimer's disease
Neuner, S. M., TCW, J., & Goate, A. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104976 · Cited by 126
“For example, rare variants in SORL1 and ABCA7 have been identified in family-based studies of LOAD (Vardarajan et al., 2015b; Raghavan et al., 2018; Cruchaga et al., 2014; Le Guennec et al., 2016), each of which have been associated with alterations in APP processing.”
BackgroundABCA7 and Pathogenic Pathways of Alzheimer’s Disease
Aikawa, T., Holm, M., & Kanekiyo, T. (2018) · Brain Sciences · doi:10.3390/brainsci8020027 · Cited by 128
Campion, D., Charbonnier, C., & Nicolas, G. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01991-4 · Cited by 124
Self-citationHoogmartens, J., Cacace, R., & Broeckhoven, C. V. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12155 · Cited by 109
17q21.31 duplication causes prominent tau-related dementia with increased MAPT expression
Guennec, K. L., Quenez, O., Nicolas, G., Wallon, D., Rousseau, S., Richard, A.-C., Alexander, J., Paschou, P., Charbonnier, C., Bellenguez, C., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.226 · Cited by 102
Self-citationAn intronic VNTR affects splicing of ABCA7 and increases risk of Alzheimer’s disease
On Behalf of the BELNEU Consortium, De Roeck, A., Duchateau, L., Van Dongen, J., Cacace, R., Bjerke, M., Van den Bossche, T., Cras, P., Vandenberghe, R., De Deyn, P. P., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1841-z · Cited by 93
Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer’s disease
On behalf of the European Early-Onset Dementia (EU EOD) consortium, De Roeck, A., Van den Bossche, T., van der Zee, J., Verheijen, J., De Coster, W., Van Dongen, J., Dillen, L., Baradaran-Heravi, Y., Heeman, B., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1714-x · Cited by 74
The Role of Genetics in Advancing Precision Medicine for Alzheimer’s Disease—A Narrative Review
Freudenberg‐Hua, Y., Li, W., & Davies, P. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00108 · Cited by 80
ABCA7 and the altered lipidostasis hypothesis of Alzheimer's disease
Lyssenko, N. N., & Praticò, D. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12220 · Cited by 67
Decreased plasma β‐amyloid in the Alzheimer's disease APP A 673 Tvariant carriers
Martiskainen, H., Herukka, S., Stančáková, A., Paananen, J., Soininen, H., Kuusisto, J., Laakso, M., & Hiltunen, M. (2017) · Annals of Neurology · doi:10.1002/ana.24969 · Cited by 64
The role of ATP-binding cassette subfamily A in the etiology of Alzheimer’s disease
Bossaerts, L., Cacace, R., & Broeckhoven, C. V. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00536-w · Cited by 56
Estrogen activates Alzheimer's disease genes
Ratnakumar, A., Zimmerman, S. E., Jordan, B. A., & Mar, J. C. (2019) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.09.004 · Cited by 52
From Common to Rare Variants: The Genetic Component of Alzheimer Disease
Nicolas, G., Charbonnier, C., & Campion, D. (2016) · Human Heredity · doi:10.1159/000452256 · Cited by 50
Self-citationThe role of de novo mutations in adult-onset neurodegenerative disorders
Nicolas, G., & Veltman, J. A. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1939-3 · Cited by 53
Self-citationWhole genome sequencing of Caribbean Hispanic families with late‐onset Alzheimer's disease
Vardarajan, B. N., Barral, S., Jaworski, J. M., Beecham, G. W., Blue, E., Tosto, G., Reyes‐Dumeyer, D., Medrano, M. Z., Lantigua, R., Naj, A. C., et al. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.537 · Cited by 46
Quenez, O., Cassinari, K., Coutant, S., Lecoquierre, F., Guennec, K. L., Rousseau, S., Richard, A., Vasseur, S., Bouvignies, E., Bou, J., et al. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-0672-2 · Cited by 46
Self-citationAlzheimer’s genes in microglia: a risk worth investigating
Sudwarts, A., & Thinakaran, G. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00679-4 · Cited by 52
Gao, C., Shen, X., Tan, Y., & Chen, S. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02580-1 · Cited by 48
Human iPSC application in Alzheimer’s disease and tau-related neurodegenerative diseases
TCW, J. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.01.043 · Cited by 39
ABCA7 loss-of-function variants, expression, and neurologic disease risk
Allen, M., Lincoln, S., Corda, M., Watzlawik, J. O., Carrasquillo, M. M., Reddy, J. S., Burgess, J. D., Nguyen, T., Malphrus, K. G., Petersen, R. C., et al. (2017) · Neurology Genetics · doi:10.1212/nxg.0000000000000126 · Cited by 37
Guennec, K. L., Veugelen, S., Quenez, O., Szaruga, M., Rousseau, S., Nicolas, G., Wallon, D., Fluchère, F., Frébourg, T., Strooper, B. D., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.04.020 · Cited by 32
Self-citationCryo‐EM structures of human ABCA7 provide insights into its phospholipid translocation mechanisms
Le, L. T. M., Thompson, J. R., Dehghani‐Ghahnaviyeh, S., Pant, S., Dang, P. X., French, J. B., Kanikeyo, T., Tajkhorshid, E., & Alam, A. (2023) · The EMBO Journal · doi:10.15252/embj.2022111065 · Cited by 31
Biallelic Loss of Function of SORL1 in an Early Onset Alzheimer’s Disease Patient
Guennec, K. L., Tubeuf, H., Hannequin, D., Wallon, D., Quenez, O., Rousseau, S., Richard, A., Deleuze, J., Boland, A., Frébourg, T., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170981 · Cited by 29
Self-citationZhao, L., He, Z., Zhang, D., Wang, G. T., Renton, A. E., Vardarajan, B. N., Nothnagel, M., Goate, A., Mayeux, R. P., & Leal, S. M. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.09.006 · Cited by 27
Nicolas, G., Zaréa, A., Lacour, M., Quenez, O., Rousseau, S., Richard, A., Bonnevalle, A., Schramm, C., Olaso, R., Sandron, F., et al. (2024) · Genetics in Medicine · doi:10.1016/j.gim.2024.101082 · Cited by 26
Self-citationRare genetic variation implicated in non-Hispanic white families with Alzheimer disease
Beecham, G. W., Vardarajan, B. N., Blue, E., Bush, W. S., Jaworski, J. M., Barral, S., DeStefano, A. L., Hamilton‐Nelson, K. L., Kunkle, B. W., Martin, E. R., et al. (2018) · Neurology Genetics · doi:10.1212/nxg.0000000000000286 · Cited by 25
Bossaerts, L., Hens, E., Cacace, R., Asselbergh, B., & Broeckhoven, C. V. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01346-3 · Cited by 21
Meta-Analysis of the Association between Variants in ABCA7 and Alzheimer’s Disease
Ma, F.-C., Wang, H.-F., Cao, X., Tan, C., Tan, L., & Yu, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180107 · Cited by 21
Jiao, B., Xiao, X., Yuan, Z., Guo, L., Liao, X., Zhou, Y., Zhou, L., Wang, X., Liu, X., Liu, H., et al. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01258-1 · Cited by 20
Specificity of ABCA7-mediated cell lipid efflux
Picataggi, A., Rodrigues, A., Cromley, D. A., Wang, H., Wiener, J. P., Garliyev, V., Billheimer, J. T., Grabiner, B. C., Hurt, J. A., Chen, A. C., et al. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159157 · Cited by 20
Rare ABCA7 variants in 2 German families with Alzheimer disease
May, P., Pichler, S., Hartl, D., Bobbili, D. R., Mayhaus, M., Spaniol, C., Kurz, A., Balling, R., Schneider, J. G., & Riemenschneider, M. (2018) · Neurology Genetics · doi:10.1212/nxg.0000000000000224 · Cited by 18
Bossaerts, L., Hens, E., Hanseeuw, B. J., Vandenberghe, R. R., Cras, P. P., Deyn, P. P. D., Engelborghs, S., & Broeckhoven, C. V. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.04.023 · Cited by 17
Analysis of high‐risk pedigrees identifies 11 candidate variants for Alzheimer's disease
Teerlink, C. C., Miller, J. B., Vance, E. L., Staley, L. A., Stevens, J., Tavana, J. P., Cloward, M. E., Page, M. L., Dayton, L., Cannon‐Albright, L., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12397 · Cited by 16
Clinical Deep Phenotyping of ABCA7 Mutation Carriers
Campbell, A. S., Ho, C. C. G., Atık, M., Allen, M., Lincoln, S., Malphrus, K., Nguyen, T., Oatman, S. R., Corda, M., Conway, O., et al. (2022) · Neurology Genetics · doi:10.1212/nxg.0000000000000655 · Cited by 14
Dementia-related genetic variants in an Italian population of early-onset Alzheimer’s disease
Bartoletti‐Stella, A., Tarozzi, M. E., Mengozzi, G., Asirelli, F., Brancaleoni, L., Mometto, N., Maserati, M. S., Baiardi, S., Linarello, S., Spallazzi, M., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.969817 · Cited by 12
Wang, L., Jiao, Y., Zhao, A., Xu, X., Ye, G., Zhang, Y., Wang, Y., Deng, Y., Xu, W. L., & Liu, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.819499 · Cited by 12
Wang, N., Pan, Y., Starling, S. C., Haskell, D. H., Quintero, A. C., Kawatani, K., Inoue, Y., Shue, F., Ma, X., Aikawa, T., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70112 · Cited by 11
Genetic architecture of neurodegenerative dementias
Clarimón, J., Moreno–Grau, S., Cervera‐Carles, L., Dols‐Icardo, O., Sánchez‐Juan, P., & Ruiz, A. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108014 · Cited by 11
ABCA7 Loss-of-Function Variants Impact Phosphatidylcholine Metabolism in the Human BrainPreprint
von Maydell, D. K., Wright, S., Pao, P., Staab, C., King, O., Spitaleri, A., Bonner, J. M., Liu, L., Yu, C. J., Chiu, C.-C., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.05.556135 · Cited by 10
Duchateau, L., Küҫükali, F., Roeck, A. D., Wittens, M. M. J., Temmerman, J., Weets, I., Timmers, M., Engelborghs, S., Bjerke, M., & Sleegers, K. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01338-y · Cited by 8
What contribution can genetics make to predict the risk of Alzheimer's disease?
Schramm, C., Wallon, D., Nicolas, G., & Charbonnier, C. (2022) · Revue Neurologique · doi:10.1016/j.neurol.2022.03.005 · Cited by 8
Self-citationNeuropsychiatric genomics in precision medicine: diagnostics, gene discovery, and translation
Need, A. C., & Goldstein, D. B. (2016) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2016.18.3/aneed · Cited by 7
Gan, J., Zhou, H., Liu, C., & Fang, L. (2023) · Neurological Sciences · doi:10.1007/s10072-023-06602-5 · Cited by 5
Input of exome sequencing in early‐onset cerebral amyloid angiopathy
Grangeon, L., Charbonnier, C., Rousseau, S., Richard, A. C., Quenez, O., Zaréa, A., Boland, A., Olaso, R., Deleuze, J., CAA study group, et al. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70027 · Cited by 4
Self-citationWang, M., Sun, L., Xu, X., Dai, R., Tan, Q., Zhu, Y., Xu, A., Zheng, W., Tu, Y., Zhou, D., et al. (2025) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzaf063 · Cited by 3
Garliyev, V., Lyssenko, C. A., Wiener, J. P., Praticò, D., & Lyssenko, N. N. (2024) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlae060 · Cited by 2
Algahtani, H. A., Shirah, B. H., Alshareef, A., Al-Qahtani, M. H., Abdulkareem, A. A., & Naseer, M. I. (2020) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2020.03033 · Cited by 2
Xi, J., Ding, D., Zhao, Q., Liang, X., Zheng, L., Guo, Q., Hong, Z., Fu, H., Xu, J., & Xiao, Q. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200317095608 · Cited by 2
Rare ABCA7 variants in Alzheimer disease
Swerdlow, R. H. (2016) · Neurology · doi:10.1212/wnl.0000000000002630 · Cited by 2
Genetics of Alzheimer's Disease: An Update
Tang, M., & Reitz, C. (2017) · Future Neurology · doi:10.2217/fnl-2017-0003 · Cited by 1
Nicolas, G., & Wallon, D. (2017) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2017.01.020
Self-citationGenetic Risk Factors for Complex Forms of Alzheimer’s Disease
Bellenguez, C., & Lambert, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-72938-1_4
Self-citationGénétique de la maladie d’Alzheimer et des maladies apparentées : qu’en sait-on en 2022 ?
Formaglio, M., Ber, I. L., & Wallon, D. (2022) · La Presse Médicale Formation · doi:10.1016/j.lpmfor.2022.01.017 · Cited by 2
Self-citationGenetica della malattia di Alzheimer
Wallon, D., & Nicolas, G. (2022) · EMC - Neurologia · doi:10.1016/s1634-7072(22)47093-0
Self-citationDuchateau, L., Küҫükali, F., Roeck, A. D., Wittens, M. M. J., Temmerman, J., Weets, I., Timmers, M., Engelborghs, S., Bjerke, M., & Sleegers, K. (2023) · Figshare · doi:10.6084/m9.figshare.24540665
Quenez, O., Schramm, C., Cassinari, K., Nicolas, A., Groeneveld, J., Huguet, G., Grenier‐Boley, B., Hulsman, M., Walters, G. B., de Rojas, I., et al. (2024) · medRxiv · doi:10.1101/2024.10.28.24314051
Self-citationAchou, R., Ayachi, O. S., Boukhenaf, Y., Laouar, R., Razika, G., Abderrahim, M., Boulala, H., Abadi, N., & Satta, D. (2025) · Archives of Biological Sciences · doi:10.2298/abs250208005a
Duchateau, L., Küҫükali, F., Roeck, A. D., Wittens, M. M. J., Temmerman, J., Weets, I., Timmers, M., Engelborghs, S., Bjerke, M., & Sleegers, K. (2024) · Figshare · doi:10.6084/m9.figshare.24540868
Angiopathie amyloïde cérébrale héréditaire
Grangeon, L., Nicolas, G., & Wallon, D. (2026) · Encyclopédie médico-chirurgicale. Neurologie · doi:10.1016/s0246-0378(26)49255-6
Self-citation
Metadata
- Authors
- Le Guennec, K., Nicolas, G., Quenez, O., Charbonnier, C., Wallon, D., Bellenguez, C., Grenier-Boley, B., Rousseau, S., Richard, A.-C., Rovelet-Lecrux, A., Bacq, D., Garnier, J.-G., Olaso, R., Boland, A., Meyer, V., Deleuze, J.-F., Amouyel, P., Munter, H. M., Bourque, G., Lathrop, M., Frebourg, T., Redon, R., Letenneur, L., Dartigues, J.-F., Pasquier, F., Rollin-Sillaire, A., Génin, E., Lambert, J.-C., Hannequin, D., Campion, D., collaborators, C.-M., Hannequin, D., Campion, D., Wallon, D., Martinaud, O., Nicolas, G., Rollin-Sillaire, A., Bombois, S., Mackowiak, M.-A., Deramecourt, V., Pasquier, F., Michon, A., Le Ber, I., Dubois, B., Duyckaerts, C., Godefroy, O., Etcharry-Bouyx, F., Chauviré, V., Chamard, L., Berger, E., Magnin, E., Dartigues, J.-F., Auriacombe, S., Tison, F., Goizet, C., Sayette, V. D. L., Viader, F., Castan, D., Dionet, E., Sellal, F., Rouaud, O., Thauvin, C., Moreaud, O., Sauvée, M., Formaglio, M., Mollion, H., Roullet-Solignac, I., Vighetto, A., Croisile, B., Didic, M., Félician, O., Koric, L., Ceccaldi, M., Gabelle, A., Marelli, C., Touchon, J., Labauge, P., Jonveaux, T., Vercelletto, M., Boutoleau-Bretonnière, C., Castelnovo, G., Renaud, D., Robert, P., Paquet, C., Dumurgier, J., Hugon, J., De Boisgueheneuc, F., Belliard, S., Bakchine, S., Sarazin, M., Barrellon, M.-O., Laurent, B., Blanc, F., Tranchant, C., Pariente, J., Puel, M., Hommet, C., & Mondon, K.
- Affiliations
- From INSERM (K.L.G., G.N., O.Q., C.C., D.W., S.R., A.C.R., A.R.-L., T.F., D.H., D.C.), U1079, IRIB, University of Rouen, Normandy University; Normandy Centre for Genomic Medicine and Personalized Medicine (K.L.G., G.N., O.Q., C.C., D.W., S.R., A.-C.R., A.R.-L., T.F., D.H., D.C.), Rouen; Department of Genetics (G.N., T.F., D.H.), CNR-MAJ (G.N., O.Q., C.C., D.W., S.R., A.-C.R., F.P., A.R.-S., D.H., D.C.), and Department of Neurology (D.W., D.H.), Rouen University Hospital; INSERM (C.B., B.G.-B., P.A.,...
- Inserm (FR)
- Centre Hospitalier Universitaire Amiens-Picardie (FR)
- Institute for Research and Innovation in Biomedicine (FR)
- Hôpital Charles-Nicolle (FR)
- ORCID
- Quenez, Olivier
- Charbonnier, Camille
- Bellenguez, Céline
- Olaso, Robert
- Boland, Anne
- Meyer, Vincent
- Deleuze, Jean-François
- Amouyel, Philippe
- Bourque, Guillaume
- Lathrop, Mark
- Redon, Richard
- Letenneur, Luc
- Génin, Emmanuelle
- Lambert, Jean-Charles
- Bombois, Stéphanie
- Deramecourt, Vincent
- Dubois, Bruno
- Duyckaerts, Charles
- Godefroy, Olivier
- Tison, François
- Goizet, Cyril
- Sayette, Vincent de la
- Viader, Fausto
- Rouaud, Olivier
- Moreaud, Olivier
- Sauvée, Mathilde
- Croisile, Bernard
- Didic, Mira
- Félician, Olivier
- Koric, Lejla
- Ceccaldi, Mathieu
- Gabelle, Audrey
- Labauge, Pierre
- Jonveaux, Thérèse
- Castelnovo, Giovanni
- Robert, Philippe
- Paquet, Claire
- Dumurgier, Julien
- Hugon, Jacques
- Belliard, Serge
- Sarazin, Marie
- Laurent, Bernard
- Blanc, Frédéric
- Tranchant, Christine
- Pariente, Jérémie
- Venue
- Neurology
- Published
- 2016-06-07
- Volume
- 86
- Issue
- 23
- Pages
- 2134-2137
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC4898320
- OpenAlex
- W2322302990
- Cited by
- 69
- References
- 28
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 5 · 2022: 13 · 2021: 4 · 2020: 7 · 2019: 6 · 2018: 12 · 2017: 10 · 2016: 4
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-11-LABX-0009)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- ABCA7, Alzheimer's disease, early-onset Alzheimer's disease, rare coding variants, loss-of-function mutations, missense mutations, genetic risk, exome sequencing, case-control association
- MeSH terms
- Aged, Alzheimer Disease, Belgium, France, Gene Frequency, Humans, Mutation, Case-Control Studies, ATP-Binding Cassette Transporters, Genetic Predisposition to Disease, Genetic Association Studies, Exome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
